Kevin R. Sayer, Executive Chair at DEXCOM INC (DXCM), sold 26,756 shares at $76.32 ($2.0M) on 2026-07-20, disclosed to the SEC on 2026-07-21.
Scheduled sale ($2.0M) by Executive Chair under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| DXCM | SELL | 2026-05-26 | $1.9M | — | Filing → |
| DXCM | SELL | 2025-03-14 | $4.6M | — | Filing → |
| DXCM | SELL | 2025-01-30 | $5.8M | — | Filing → |